Ovid Therapeutics Inc

NASDAQ:OVID  
3.47
+0.01 (+0.29%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)236.59M
Current PEN/A
Forward PE 3.58
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.37 Million
Adjusted EPS$1.45
See more estimates
10-Day MA$3.63
50-Day MA$3.83
200-Day MA$4.58
See more pivots

Ovid Therapeutics Inc Stock, NASDAQ:OVID

1460 Broadway, Suite 15021, New York, New York 10036
United States of America
Phone: +1.646.661.7661
Number of Employees: 67

Description

Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.